Ofirmev growth back to original growth levels??

Discussion in 'Cadence Pharmaceuticals' started by Anonymous, Nov 25, 2014 at 10:07 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Get ready for a rude awakening, based on Hugh's history, when the company or Ofirmev don't hit projected growth . All about bottom line with him.
     

  2. Anonymous

    Anonymous Guest

    Don't worry. We will get an easy $41 M from from surgery centers. Piece of cake.
     
  3. Anonymous

    Anonymous Guest

    Everyone is leaving after we get 4th qtr pay out in Feb.
     
  4. Anonymous

    Anonymous Guest

    Why wait. They owe you for the % of qtr you worked regarding bonus. SIP states you dont have to be here the day the check is cut. That is only for retention bonus. Read the recent sip and if you read it differently let me know but that is how i read it.

    cheers
     
  5. Anonymous

    Anonymous Guest

    Do the math. What did we sell in the stub period? Take that and subtract it from 350 million and you will have the answer on the futility of the plan.
     
  6. Anonymous

    Anonymous Guest

    This is all a futile effort to temporarily raise the stock price in a strategically calculated plan.